The Infusions (India) Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 23-06-2024
- Paid Up Capital ₹ 7.73 Cr
as on 23-06-2024
- Company Age 47 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
About The Infusions (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rupam Banerjee, Biswanath Chakrabarti, and Salil Chatterjee serve as directors at the Company.
- CIN/LLPIN
U85195WB1976SGC030823
- Company No.
030823
- Company Classification
Public Limited State Government Company
- Incorporation Date
22 Dec 1976
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at The Infusions (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Biswanath Chakrabarti  | Managing Director | 08-Jun-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rupam Banerjee | Director | 18-Apr-2024 | Current |
| Salil Chatterjee | Director | 30-Jul-1997 | Current |
Financial Performance and Corporate Structure Insights of The Infusions (India).
Enhance accessibility to The Infusions (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of The Infusions (India)?
Unlock access to The Infusions (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
West Bengal Pharmaceutical & Phytochemical Development Corporation LtdActive 50 years 8 monthsRupam Banerjee is a mutual person
Greater Calcutta Gas Supply Corpn LtdActive 36 years 11 monthsBiswanath Chakrabarti is a mutual person
West Bengal Industrial Development Corpn LtdActive 57 years 11 monthsRupam Banerjee is a mutual person
West Bengal Sugar Industries Development Corpn LimitedActive 51 years 6 monthsBiswanath Chakrabarti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at The Infusions (India)?
The Infusions (India) has a workforce of 22 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of The Infusions (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped The Infusions (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
